The acquisition keeps the Lockport facility fully operational, with Valiant pledging to function as an active owner rather than a passive investor. Nigel Solida, CEO of Valiant, emphasized that the decision to purchase the firm was driven by the specialized technical infrastructure and the workforce that has sustained the business through previous industry challenges. Valiant plans to reinvest in manufacturing capabilities and prioritize innovation to expand the company’s footprint in biotechnology and agricultural markets.
Scott Bernstein, CFO of Valiant, noted that VanDeMark aligns with the firm’s strategy of identifying businesses with strong fundamental assets that require targeted operational support. Financial guidance for the transaction was provided by Young & Partners, while Blank Rome LLP served as legal counsel for Valiant. The sellers were advised by Balmoral Advisors.




Comments (0)
No comments yet. Be the first!